s
Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally
11-12-2024, 12:23
BASEL, Switzerland and BOSTON, Dec. 11, 2024 /PRNewswire/ — Lyfegen, a global leader in drug rebate management technology, today announced the successful close of its additional CHF 5 million Series A funding round. The round was led by TX Ventures, a leading European fintech investor, with additional participation from aMoon, a global health-tech venture capital […] L'articolo Lyfegen Secures additional CHF 5 Million in Series A Funding to Scale Its Drug Rebate Management Platform Globally proviene da La Ragione.
CONTINUA A LEGGERE
18
0
0
Guarda anche
La Ragione
01:43
Trump “Dazi reciproci del 20% per l’Unione Europea”
La Ragione
Ieri, 22:02
**Messina: gip, ‘Argentino dopo il delitto non ha manifestato alcun segno di pentimento’**
La Ragione
Ieri, 21:44